Simar-Blanchet A E, Legraverend C, Thissen J P, Le Cam A
Laboratoire INSERM U376, Hôpital Arnaud de Villeneuve, Montpellier, France.
Mol Endocrinol. 1998 Mar;12(3):391-404. doi: 10.1210/mend.12.3.0080.
Two GH-response elements (GHREs) and a single glucocorticoid (GC)-response element were found to regulate activity of the rat serine protease inhibitor 2.1 gene (spi 2.1) promoter in vitro. To assess the physiological relevance of these observations, we have investigated the relationship existing between the level of spi 2.1 gene transcription, structural modifications of the chromatin, and in vivo nuclear protein-promoter interactions monitored by genomic footprinting, in control, hypophysectomized, and inflamed rats. We also addressed the mechanism of inflammation-mediated gene down-regulation. We found that a high level of spi 2.1 gene transcription correlates with hypersensitivity of the promoter to deoxyribonuclease I (DNase I) and maximal occupancy of the GAGA box (GHRE-I). The failure of GAGA-box binding proteins (GAGA-BPs) to interact with the GAGA box appears to result from an impairment in GH action due to its absence (i.e. hypophysectomized animals) or to the appearance of a cytokine-mediated GH-resistant state (i.e. inflamed rats) in liver. Unlike the GAGA box, signal transducer and activator of transcription (STAT) factor-binding sites included in the GHRE-II were never found to be protected against DNase I attack but displayed a differential DNase I reactivity depending on the level of gene transcription. Alterations in DNase I reactivity of the GC-response element region suggest that GC receptor-GC complexes may associate, in a transient manner, with the promoter in the actively transcribing control state. Taken together, our studies suggest a mechanism of spi 2.1 gene activation in vivo whereby the GH-dependent chromatin remodeling caused by or concomitant to the recruitment of GAGA-box binding proteins is the first compulsory and presumably predominant step.
研究发现,两个生长激素反应元件(GHREs)和一个糖皮质激素(GC)反应元件可在体外调节大鼠丝氨酸蛋白酶抑制剂2.1基因(spi 2.1)启动子的活性。为了评估这些观察结果的生理相关性,我们研究了对照、垂体切除和炎症大鼠中spi 2.1基因转录水平、染色质结构修饰以及通过基因组足迹监测的体内核蛋白与启动子相互作用之间的关系。我们还探讨了炎症介导的基因下调机制。我们发现,高水平的spi 2.1基因转录与启动子对脱氧核糖核酸酶I(DNase I)的超敏反应以及GAGA盒(GHRE-I)的最大占有率相关。GAGA盒结合蛋白(GAGA-BPs)无法与GAGA盒相互作用,这似乎是由于肝脏中生长激素作用受损,这种受损是由于生长激素缺乏(即垂体切除的动物)或细胞因子介导的生长激素抵抗状态的出现(即炎症大鼠)所致。与GAGA盒不同,GHRE-II中包含的信号转导和转录激活因子(STAT)结合位点从未被发现能免受DNase I攻击,但根据基因转录水平显示出不同的DNase I反应性。GC反应元件区域的DNase I反应性改变表明,GC受体-GC复合物可能以瞬时方式与处于活跃转录控制状态的启动子结合。综上所述,我们的研究提出了一种体内spi 2.1基因激活的机制,即由GAGA盒结合蛋白的募集引起或伴随的生长激素依赖性染色质重塑是第一个必要且可能占主导地位的步骤。